Acquired technology Neosensory же discontinued operations after selling its technology to a larger company. This signals a potential sales window for partners or competitors in the hearing and sensory tech space to pursue complementary solutions, integration services, or legacy device support.

Tinnitus relief platform Duo tinnitus program achieved reported clinical effectiveness and remains a reference for bimodal stimulation combining sound and touch. Potential upsell opportunities exist with clinics, audiology networks, and health systems seeking validated non-invasive modalities.

Hearing loss aids Clarify was launched as a speech understanding solution for hearing loss. This indicates market interest in assistive hearing technologies that improve intelligibility, presenting potential collaborations with audiology distributors and hearing aid manufacturers.

Strategic partnerships Board-level and advisory appointments suggest ongoing governance and strategy alignment. Engage with Neosensory's former ecosystem through potential licensing, co-development, or transition services with the acquiring company or related entities.

lean operations Small team size and revenue under one million imply limited internal sales capacity. This creates an opportunity for channel partners, OEMs, or systems integrators to step in with distribution, integration, and customer support capabilities in related markets.